Health A-Z
Find Services & Information
Diseases & Conditions Results: 1-6 of 6 Web Pages
FDA approved a new label with upgraded warnings for Bextra. Bextra is a type of pain medication, called COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs), used to treat arthritis and mens... Details >
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Based on emerging information, including preliminary reports from one of several long term National Institutes of Health (NIH) prevention studies, the risk of cardiovascular events may be increased in... Details >
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
The Food and Drug Administration (FDA) today issued a Public Health Advisory summarizing the agency's recent recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs... Details >
Based on emerging information from a long-term prevention trial, the risk of cardiovascular and cerebrovascular events may increase among patients taking naproxen (Aleve, Naprosyn, Anaprox, Naprelan).... Details >
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Merck & Co., Inc. announced a voluntary withdrawal of Vioxx (rofecoxib) from the U.S. and worldwide market due to safety concerns of an increased risk of cardiovascular events (including heart attack ... Details >
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Vioxx has been voluntarily recalled from the worldwide market. Vioxx is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). Vioxx is also related to the nonselective NSAIDs , such as ibup... Details >
Center for Drug Evaluation and Research, U.S. Food and Drug Administration